Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC

被引:34
作者
Unger, K. [1 ,2 ]
Malisch, E. [1 ]
Thomas, G. [2 ]
Braselmann, H. [1 ]
Walch, A. [3 ]
Jackl, G. [1 ]
Lewis, P. [4 ]
Lengfelder, E. [5 ]
Bogdanova, T. [6 ]
Wienberg, J. [7 ]
Zitzelsberger, H. [1 ]
机构
[1] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Inst Mol Strahlenbiol, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany
[2] Hammersmith Hosp, Dept Histopathol, London W12 0HS, England
[3] Deutsch Forschungszentrum Gesundheit & Umwelt Gmb, Helmholtz Zentrum Munchen, Inst Pathol, D-85764 Neuherberg, Germany
[4] Swansea Univ, Swansea Med Sch, Swansea, W Glam, Wales
[5] Univ Munich, Inst Strahlenbiol, Munich, Germany
[6] Ukraine Acad Med Sci, Inst Endocrinol & Metab, Kiev, Ukraine
[7] Univ Munich, Dept Biol 2, Munich, Germany
关键词
papillary thyroid carcinoma; array CGH; RET/PTC; candidate genes; tumour development; aberration signature;
D O I
10.1038/onc.2008.99
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this study is to investigate additional genetic alterations in papillary thyroid carcinomas (PTCs) with known RET/PTC rearrangements. We applied array-based comparative genomic hybridization (array CGH) to 33 PTC (20 PTC from adults, 13 post-Chernobyl PTC from children) with known RET/PTC status. Principal component analysis and hierarchical cluster analysis identified cases with similar aberration patterns. Significant deviations between tumour-groups were obtained by statistical testing (Fisher's exact test in combination with Benjamini-Hochberg FDR-controlling procedure). FISH analysis on FFPE sections was applied to validate the array CGH data. Deletions were found more frequently in RET/PTC-positive and RET/PTC-negative tumours than amplifications. Specific aberration signatures were identified that discriminated between RET/PTC-positive and RET/PTC-negative cases (aberrations on chromosomes 1p, 3q, 4p, 7p, 9p/q, 10q, 12q, 13q and 21q). In addition, childhood and adult RET/PTC-positive cases differ significantly for a deletion on the distal part of chromosome 1p. There are additional alterations in RET/PTC-positive tumours, which may act as modifiers of RET activation. In contrast, alterations in RET/PTC-negative tumours indicate alternative routes of tumour development. The data presented serve as a starting point for further studies on gene expression and function of genes identified in this study.
引用
收藏
页码:4592 / 4602
页数:11
相关论文
共 71 条
[1]   Patched1 functions as a gatekeeper by promoting cell cycle progression [J].
Adolphe, C ;
Hetherington, R ;
Ellis, T ;
Wainwright, B .
CANCER RESEARCH, 2006, 66 (04) :2081-2088
[2]   Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma [J].
Azuma, K ;
Tanaka, M ;
Uekita, T ;
Inoue, S ;
Yokota, J ;
Ouchi, Y ;
Sakai, R .
ONCOGENE, 2005, 24 (30) :4754-4764
[3]   Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma [J].
Camacho-Vanegas, Olga ;
Narla, Goutham ;
Teixeira, Miriam S. ;
DiFeo, Analisa ;
Misra, Anjan ;
Singh, Gobind ;
Chan, Andrew M. ;
Friedman, Scott L. ;
Feuerstein, Burt G. ;
Martignetti, John A. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (06) :1390-1395
[4]   RMI1/NCE4, a suppressor of genome instability, encodes a member of the RecQ helicase/Topo III complex [J].
Chang, M ;
Bellaoui, M ;
Zhang, CY ;
Desai, R ;
Morozov, P ;
Delgado-Cruzata, L ;
Rothstein, R ;
Freyer, GA ;
Boone, C ;
Brown, GW .
EMBO JOURNAL, 2005, 24 (11) :2024-2033
[5]   Molecular basis of Hurthle cell papillary thyroid carcinoma [J].
Cheung, CC ;
Ezzat, S ;
Ramyar, L ;
Freeman, JL ;
Asa, SL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :878-882
[6]   Identification of an alternatively spliced RNA for the Ras suppressor RSU-1 in human gliomas [J].
Chunduru, S ;
Kawami, H ;
Gullick, R ;
Monacci, WJ ;
Dougherty, G ;
Cutler, ML .
JOURNAL OF NEURO-ONCOLOGY, 2002, 60 (03) :201-211
[7]   Minireview: RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis [J].
Ciampi, Raffaele ;
Nikiforov, Yuri E. .
ENDOCRINOLOGY, 2007, 148 (03) :936-941
[8]  
COLLINS CM, 1996, P INT SOC MAGN RES M, V1, P253
[9]   One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma [J].
Corson, Timothy W. ;
Gallie, Brenda L. .
GENES CHROMOSOMES & CANCER, 2007, 46 (07) :617-634
[10]   RAI(ShcC/N-Shc)-dependent recruitment of GAB1 to RET oncoproteins potentiates PI3-K signalling in thyroid tumors [J].
De Falco, V ;
Guarino, V ;
Malorni, L ;
Cirafici, AM ;
Troglio, F ;
Erreni, M ;
Pelicci, G ;
Santoro, M ;
Melillo, RM .
ONCOGENE, 2005, 24 (41) :6303-6313